Prot# P04737: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects with a History of Atherosclerotic Disease: Thrombin Receptor Antagonist in Second

Project: Research project

Project Details

StatusFinished
Effective start/end date9/15/089/15/14

Funding

  • Schering-Plough Research Institute (P04737)